iECURE, Inc., a clinical-stage genome editing company developing variant-agnostic in vivo targeted gene insertion therapies for the treatment of severe, inherited, neurometabolic disorders, today ...
PRINCETON, N.J., March 4, 2026 /PRNewswire/ -- Kenox Pharmaceuticals Inc. (Kenox), a fast‑growing contract development and manufacturing organization (CDMO) dedicated exclusively to Orally Inhaled and ...
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic ...
Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of hematological malignancies, today announced that the U.S. Food and Drug ...
The state is providing more than $800,000 to a New Haven nonprofit that will use the money for a grant program to promote manufacturing innovation and product development. The program was announced ...
PHILADELPHIA, PA — iECURE said the U.S. Food and Drug Administration has selected ECUR-506, the company’s investigational ...
Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...
Technical personnel such as engineers and designers need to have input on a device's features and intended functions. In the fiercely competitive medical device and instrumentation industry, speeding ...
When state lawmakers last month faced a $2 billion drop in projected revenue for the next two-year budget, they turned in part to a handful of line items for economic development grant programs and ...
ROCHESTER, N.Y., March 03, 2026 (GLOBE NEWSWIRE) -- Underestimating costs and choosing the wrong partners are the primary reasons hardware startups fail. To bridge this gap, NextCorps is now accepting ...
COmposite Fitting Attachment (COFA) technology is a method of rapidly welding “non-structural” brackets to composite structures. It was invented by CRC-ACS and is under development as part of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results